Effect of beta-lactamase inhibitors on normal immune capabilities and their interactions with staphylococcal pathogenicity

Journal of Chemotherapy

Volumn 8, Issue 2, 1996, Pages 102-106

  Tawfik, A F ^a   Al Zamil, F A ^a   Ramadan, M A ^b   Shibl, A M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Beta lactamase; Clavulanic acid; Inhibitors; Staphylococcus aureus; Sulbactam; Tazobactam

Indexed keywords

BETA LACTAMASE INHIBITOR; CLAVULANIC ACID; SULBACTAM; TAZOBACTAM;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; NONHUMAN; PATHOGENICITY; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODY FORMATION; BACTERIAL ADHESION; BETA-LACTAMS; EPITHELIAL CELLS; HUMANS; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; NEUTROPHILS; STAPHYLOCOCCUS AUREUS;

EID: 0029926338     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.2.102     Document Type: Article

References (15)

1. Labro MT. Immunomodulation by antibacterial agents. Is it clinically relevant? Drugs 1993; 45(3): 319-328.
2. Thong YH. Immunomodulation by antimicrobial agents. In: Jeljaszewicz J and Pilverer G eds. Antimicrobial agents and immunity. London: Academic Press 1986: 87-129.
3. Itokazu GS, Danziger LH. Ampicillin-sulbactam and ticarcillin-clavulanic acid: A comparison of their in-vitro activ-ity and a review of their clinical efficacy. Pharmacotherapy 1991; 11(5): 382-414.
4. Tawfik AF, Colley DG. Effect of antischistosomal chemotherapy on immune responses, protection and immunity III. An effective regimen of praziquantel does not alter immune capabilities of normal mice. Am J Trop Med Hygiene 1986; 35: 118-123.
5. Tawfik AF, Shoeb HA, Bishop SJ, Al-Shammary FJ, Shibl AM. Influence of new quinolones on immune capabilities. J Chemother 1990; 2: 300-305.
6. Shibl AM, Gemmell CG. Effect of four antibiotics on hemolysin production and adherence to human uroepithelial cells by Escherichia coli. J Med Microbiol 1983; 16: 341-349.
7. Solberg CO, Dignanes A, Kalager T. Therapy of staphylococcal septicemia in immunocompromised hosts. Scand J Infect Dis 1983; suppl. 41: 177-184.
8. Ogawa M, Goto S, Ishi-Kawa F, Kimura I. Effect of various antibiotics on antibody producing cells of mouse spleen. Chemotherapy 1986; 32: 464-467.
9. Chaperon EA, Sanders WE Jr. Suppression of lymphocyte responses by cephalosporins. Infect Immun 1978; 19(2); 378-384.
10. Roskowski WKO, Roskowski HL, Jeljaszewicz J, Pulverer G. Antibiotics and immunomodulation effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindomycin. Med Microbiol Immunol 1985; 173: 279-289.
11. Pascual A, Conejo MC, Lopezlopez G, Perea EJ. Effect of ampicillin/sulbactam on human polymorphonuclear leukocytes function. Chemotherapy 1991; 37: 335-342.
12. Pascual A, Martinez Martinez L, Aragon J, Perea EJ. Effect of amoxycillin and clavulanic acid, alone and in combination on human polymorphonuclear leukocyte function against Staphylococcus aureus. Eur J Clin Microbiol 1989; 8(4): 277-281.
13. Gunther MR, Mao J, Cohen MS. Oxidant scavenging activities of ampicillin and sulbactam and their effects on neutrophil functions. Antimicrob Agents Chemother 1993; 37(5): 950-956.
14. Lorian V, Gemmell CG. Effect of low antibiotic concentrations on bacteria: effect of ultrastructure virulence and susceptibility to defenses. In: Lorian V Ed. Antibiotics in laboratory medicine. London: Williams and Wilkins 1991: 493.
15. Yeaman MR, Sulam PM PM, Dazin PF, Bayer AS. Antibiotic induced enhancement of Staphylococcus aureus adherence to platelets is reversed by platelet microbicidal protein. 33rd ICAAC, New Orleans, LA, 1993: Abstr. n. 149: 146.